Completed
A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis (COAST-X)
I1F-MC-RHBX - ClinicalTrials.gov - NCT02757352
The main purpose of this study is to evaluate the safety and efficacy of the study drug known as ixekizumab in biologic disease modifying antirheumatic drug (bDMARD) naïve participants with nonradiographic axial spondyloarthritis (nonrad-axSpA).
How long will I be in the trial?
Your participation could last up to 1 ½ years and include 15 visits to the study center. After this study, you may be eligible to enter another study that could last up to 2 more years.
Completed
A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis (COAST-X)
I1F-MC-RHBX - ClinicalTrials.gov - NCT02757352
The main purpose of this study is to evaluate the safety and efficacy of the study drug known as ixekizumab in biologic disease modifying antirheumatic drug (bDMARD) naïve participants with nonradiographic axial spondyloarthritis (nonrad-axSpA).
How long will I be in the trial?
Your participation could last up to 1 ½ years and include 15 visits to the study center. After this study, you may be eligible to enter another study that could last up to 2 more years.
Key Requirements
Age :
18+
Sex:
All
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participants must NOT
Trial Summary
Conditions the trial is for
Nonradiographic Axial Spondyloarthritis
What the trial is testing?
interventions example
Could I receive a Placebo?
yes
Enrollment Goal
300
Trial Dates
August 2016 - May 2019
Trial Phase
3
Enter your postal code to find the nearest site
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participants must NOT
Trial Summary
Conditions the trial is for
Nonradiographic Axial Spondyloarthritis
What the trial is testing?
interventions example
Could I receive a Placebo?
yes
Enrollment Goal
300
Trial Dates
August 2016 - May 2019
Trial Phase
3
Not the right fit? Sign up to receive updates on new Nonradiographic Axial Spondyloarthritis trials.
Trial Locations
Hide locations not currently recruiting
Enter your postal code to see sites near you
By clicking the checkbox and using the map, you agree to allow Google Maps to collect your personal information in accordance with their Privacy Policy
Nonradiographic Axial Spondyloarthritis Resources
